The Psychological, Social, and Economic Impacts of COVID-19 (C19Survey)

April 28, 2020 updated by: Rébecca Robillard, University of Ottawa

How Are You Coping? Assessing the Psychological, Social, and Economic Impacts of an Emerging Pandemic

A dynamic analytical tool is being implemented to monitor the health, psychosocial and economic impacts of the COVID-19 pandemic as the crisis unfolds. A longitudinal survey is distributed via a network of hospitals, provincial/national organizations and web platforms. The survey information can be linked to provincial health administrative data and metrics derived from social media activity based on artificial intelligence methods. Targeted questions are included for critical populations such as healthcare workers and people with chronic illnesses.

Study Overview

Status

Unknown

Conditions

Detailed Description

The current situation unfolding with regards to the COVID-19 virus is changing core aspects of people's lives in a unique manner. This study aims to examine the psychological, social, and financial impacts of the COVID-19 pandemic at various stages of the outbreak.

Individuals 12 years and older are recruited from three main groups: general population, people with chronic illnesses and healthcare professionals.

An online survey is distributed via multiple hospitals, provincial/national organizations, and web-based platforms at various phases of the outbreak. The survey includes validated questionnaires and custom-made questions to asses the current situation. It notably addresses the following themes: demographics, COVID-19 symptoms and diagnoses, social distancing practices and social interactions, living situation, financial situation, family and work-related challenges, access to healthcare, as well as sleep, physical and mental health.

The survey is available in English and French. It is built on a decisional tree structure with customized subsets of questions based on previous answers.The survey contains an adolescent version and an adult version, and also includes targeted questions for individuals with a current diagnosis of a mental/medical illness. Consent is also sought to link data from parent-child dyads to enable finer analyses of family dynamics. Healthcare staff are invited to answer questions about work-related difficulties, usefulness of virtual tools for clinical practice, as well as moral distress and moral resilience in the context of clinical practice. Healthcare staff who are short on time can chose fill out an abbreviated version. Participants have the option of enabling linkage to linked to provincial health administrative data, and to provide their twitter and facebook handle for social media and mood monitoring through artificial intelligence algorithms. Participants have the option of being followed longitudinally during and after the outbreak.

Study Type

Observational

Enrollment (Anticipated)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Newmarket, Ontario, Canada, L3Y 2P9
        • Not yet recruiting
        • Southlake Regional Health Centre
        • Contact:
        • Principal Investigator:
          • Janet Jeffrey, RN, PhD
      • Ottawa, Ontario, Canada, K1Z 7K4
        • Recruiting
        • The Royal's Institute of Mental Health Research
        • Contact:
        • Principal Investigator:
          • Rébecca Robillard, PhD
        • Sub-Investigator:
          • Zachary Kaminsky, PhD
        • Sub-Investigator:
          • Raj Bhatla, MD FRCPC
        • Sub-Investigator:
          • Mysa Saad, MSc
        • Sub-Investigator:
          • Jennifer Phillips, PhD
      • Ottawa, Ontario, Canada, K1H 5B2
        • Recruiting
        • CHEO Research Institute
        • Contact:
        • Principal Investigator:
          • Addo Boafo, MD
      • Ottawa, Ontario, Canada, K1H 8L6
        • Recruiting
        • The Ottawa Hospital Research Institute
        • Contact:
        • Principal Investigator:
          • Tetyana Kendzerska, MD, PhD
        • Sub-Investigator:
          • Edward Spilg, FRCP, MSc
        • Sub-Investigator:
          • Mamta Gautam, FRCP MBA
        • Sub-Investigator:
          • Cynda Rushton, RN, PhD
        • Sub-Investigator:
          • Wendy Gifford, RN, PhD
      • Ottawa, Ontario, Canada, K1S 1V7
        • Not yet recruiting
        • The Centre for Addiction and Mental Health
        • Contact:
        • Principal Investigator:
          • Lena Quilty, PhD, CPsych
        • Sub-Investigator:
          • Alexander Daros, PhD, CPsych
      • Ottawa, Ontario, Canada, K1Y 4W7
        • Recruiting
        • The University of Ottawa Heart Institute
        • Contact:
        • Principal Investigator:
          • Jodi Edwards, PhD
      • Toronto, Ontario, Canada, M4N 3M5
        • Not yet recruiting
        • Sunnybrook Health Sciences Centre
        • Contact:
        • Contact:
        • Principal Investigator:
          • Richard H Swartz, MD, PhD
    • Quebec
      • Montréal, Quebec, Canada, H1E 1A4
        • Not yet recruiting
        • Hôpital en santé mentale Rivière-des-Prairies (CIUSSS du Nord-de-l'Île-de-Montréal)
        • Contact:
        • Principal Investigator:
          • Roger Godbout, PhD
        • Sub-Investigator:
          • Marie-Hélène Pennestri, PhD
      • Montréal, Quebec, Canada, H3A 0G4
        • Not yet recruiting
        • McGill University
        • Contact:
        • Principal Investigator:
          • Marie-Hélène Pennestri, PhD
        • Sub-Investigator:
          • Elizaveta Solomonova, PhD
        • Sub-Investigator:
          • Samuel Paul Louis Veissière, PhD
      • Montréal, Quebec, Canada, H3T 1J4
        • Not yet recruiting
        • University of Montreal
        • Contact:
        • Principal Investigator:
          • Denis Lafortune, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years and older (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Participants will be recruited from 3 groups: general population, individuals with chronic illnesses, and healthcare professionals

Description

Inclusion Criteria:

  • All individuals who are at least 12 years of age

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mental health - Stress
Time Frame: through study completion, estimated to 8 months
Cohen's Perceived Stress Scale (scores ranged from 0 to 40, higher scores indicating worse stress)
through study completion, estimated to 8 months
Mental health - Anxiety
Time Frame: through study completion, estimated to 8 months
Generalized Anxiety Disorder Scale (scores ranged from 0 to 21, higher scores indicating worse anxiety)
through study completion, estimated to 8 months
Mental health - Depression
Time Frame: through study completion, estimated to 8 months
Quick Inventory of Depressive Symptomatology-Self-report, short version (scores ranged from 0 to 27, higher scores indicating worse depression)
through study completion, estimated to 8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Moral distress in healthcare workers
Time Frame: through study completion, estimated to 8 months
Measure of Moral Distress - Healthcare Professionals (scores ranged from 0 to 432, higher scores indicating worse moral distress)
through study completion, estimated to 8 months
Moral resilience in healthcare workers
Time Frame: through study completion, estimated to 8 months
Rushton Moral Resilience Scale (scores ranged from 1 to 4, higher scores indicating more resiliency)
through study completion, estimated to 8 months
Social life
Time Frame: through study completion, estimated to 8 months
Frequency of interacting with other people (daily, weekly, monthly, less often than monthly)
through study completion, estimated to 8 months
COVID-9 symptoms
Time Frame: through study completion, estimated to 8 months
Fever, Cough, Difficulty breathing or shortness of breath, Tiredness, Aches and pains, Nasal congestion, Runny nose, Sore throat, Diarrhea (Mild Moderate, Severe, N/A)
through study completion, estimated to 8 months
Adverse health long-term outcome
Time Frame: 5 years before the outbreak and two years after
Mortality (Yes/No): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx
5 years before the outbreak and two years after
Health care utilization - Inpatient
Time Frame: 5 years before the outbreak and two years after
Hospitalizations (total number): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx
5 years before the outbreak and two years after
Health care utilization - ER
Time Frame: 5 years before the outbreak and two years after
Emergency Department visits (Total number): https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx
5 years before the outbreak and two years after
Health care utilization - Outpatient
Time Frame: 5 years before the outbreak and two years after
Outpatient visits: https://datadictionary.ices.on.ca/Applications/DataDictionary/Default.aspx
5 years before the outbreak and two years after
Sleep
Time Frame: through study completion, estimated to 8 months
Pittsburgh Sleep Quality Index (scores ranged from 0 to 21, higher scores indicating worse sleep disturbances)
through study completion, estimated to 8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Ottawa

Collaborators

Johns Hopkins University
Sunnybrook Health Sciences Centre
McGill University
Centre for Addiction and Mental Health
Ottawa Heart Institute Research Corporation
Université de Montréal
Hopital du Sacre-Coeur de Montreal
Southlake Regional Health Centre
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal
The Ottawa Hospital Research Institute
The Royal's Institute of Mental Health Research
Cheo Research Institute

Investigators

  • Principal Investigator: Rébecca Robillard, PhD, University of Ottawa

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

April 3, 2020

Primary Completion (ANTICIPATED)

April 3, 2021

Study Completion (ANTICIPATED)

April 3, 2021

Study Registration Dates

First Submitted

April 20, 2020

First Submitted That Met QC Criteria

April 28, 2020

First Posted (ACTUAL)

April 30, 2020

Study Record Updates

Last Update Posted (ACTUAL)

April 30, 2020

Last Update Submitted That Met QC Criteria

April 28, 2020

Last Verified

April 1, 2020

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2131

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe